Sort
30,917 grants matching “tumor microenvironment”
Significance of Microenvironment for Prostate Cancer Initiation and Progression
$913,934Stephen R Plymate · University Of Washington · U54 · FY2009 · CA
Incorporating Phase I/II drug/chemical metabolism in HTS via micro scale co-culture
$913,343Jose Antonio Jimenez-Torres · Onexio Biosystems, Llc · R44 · FY2020 · ES
Investigating molecular and cellular mechanisms of SCLC development to identify novel therapeutic strategies
$913,132Julien Sage · Stanford University · R35 · FY2024 · CA
ULTRASMALL PSMA-TARGETED PARTICLE RADIOTHERAPY FOR REGULATING THE IMMUNOSUPPRESSIVE PROSTATE CANCER TUMOR MICROENVIRONMENT AND ENHANCING TREATMENT EFFICACY
$912,321Weill Medical College Of Cornell University · · FY2025 · Defense Health Agency
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2020 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2016 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2021 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2017 · CA
Viral priming and targeting NK cells against solid tumor malignancies
$912,000Jeffrey S Miller · University Of Minnesota · R35 · FY2015 · CA
The Role of Stem Cells and the Microenvironment in Gastrointestinal Cancers
$912,000Timothy Cragin Wang · Columbia University Health Sciences · R35 · FY2018 · CA
Decoding and Targeting the PI3K-mTOR Signaling Network in Cancer
$911,728Brendan D. Manning · Harvard University D/B/A Harvard School Of Public Health · R35 · FY2024 · CA
PREVENT EFFICACY POOL: PREVENT CANCER PRECLINICAL DRUG DEVELOPMENT PROGRAM
$911,531Chinthalapally Rao · University Of Oklahoma Hlth Sciences Ctr · N01 · FY2021 · CA
Targeting breast cancer stem cells
$911,400Max S. Wicha · University Of Michigan At Ann Arbor · R35 · FY2022 · CA
Cytokine Gene Therapy of Cancer - Preclinical Studies
$911,332University Of Pittsburgh At Pittsburgh · P01 · FY2005 · CA
Radiation response within the tumor microenvironment
$910,791Stephen J. Kron · University Of Chicago · R01 · FY2014 · CA
Pathomic Predictors of Prostate Cancer Progression
$910,446Parag Kumar Mallick · Stanford University · R01 · FY2020 · CA
Cancer Immunotherapy Trials Network Central Operations and Statistical Center
$910,425Martin Cheever · Fred Hutchinson Cancer Research Center · U01 · FY2013 · CA
Defining the Role of Tumor-Neutral Crosstalk in head and Neck Cancer Progression and Treatment Resistance
$910,254Moran Amit · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$909,837Ronald Levy · Stanford University · R35 · FY2017 · CA
Human Monoclonal Antibodies Against Cancer
$909,717Dimiter S Dimitrov · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
TMEM, MENAcalc, and MENAINV as Prognostic and Predictive Markers for Breast Cancer Metastasis
$909,583Thomas E Rohan · Albert Einstein College Of Medicine · R01 · FY2020 · CA
Initiation of Diffuse and Intestinal Non-Cardia Gastric Cancer
$908,985Sandra W Ryeom · Columbia University Health Sciences · R01 · FY2023 · CA
Towards targeting the lymphoma microenvironment
$908,577Hans-Guido Wendel · Sloan-Kettering Inst Can Research · R35 · FY2023 · CA
Tumor microenvironments determing migration, dissemination and dormancy
$908,453John S Condeelis · Albert Einstein College Of Medicine · U54 · FY2013 · CA
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
$907,540Harriet M Kluger · Yale University · K12 · FY2020 · CA